Andy Lundin, Author at Advanced Oncology

CRISPR-Cas9 in Molecular Pathology: Transforming Cancer Genomics

CRISPR-Cas9 is transforming cancer treatment by enabling precise genome editing, leading to therapeutic strategies and personalized medicine.

Chemotherapy drugs are essential in cancer treatment, targeting rapidly dividing cells to prevent tumor growth and proliferation.

Posted by Andy Lundin | Jun 4, 2024 | Pharmacogenomics |

Integrating pharmacogenomic data into clinical practice for cancer treatment enables personalized therapies that enhance drug efficacy.

Posted by Andy Lundin | Jun 4, 2024 | Hormonal Agents |

Hormonal therapies are essential in managing prostate cancer by reducing androgen levels or blocking their effects.

Posted by Andy Lundin | Jun 4, 2024 | Hormonal Agents |

Hormonal therapies play a role in treating hormone receptor-positive breast cancer by targeting estrogen pathways to inhibit cancer growth.